Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group None., (2021), Lancet, 397, 605 - 612

Haemodialysis, blood pressure and risk: at the limit of non-randomized evidence.


Ng SYA. et al, (2020), Nephrol Dial Transplant

In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes.

Journal article

Ai Ng SY. et al, (2020), Ann Intern Med, 172

Renal failure and its treatment

Journal article

Ng S. and Hanison J., (2018), Anaesthesia & Intensive Care Medicine, 19, 217 - 223

Dynapenic obesity and the risk of incident Type 2 diabetes: the English Longitudinal Study of Ageing

Journal article

Cuthbertson DJ. et al, (2016), Diabetic Medicine, 33, 1052 - 1059

Liraglutide in the treatment of obesity

Journal article

Ng SYA. and Wilding JPH., (2014), Expert Opinion on Biological Therapy, 14, 1215 - 1224